Salter AI - Search Results

1

B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma Model.

Zhang S, Black RG, Kohli K, Hayes BJ, Miller C, Koehne A, Schroeder BA, Abrams K, Schulte BC, Alexiev BA, Heimberger AB, Zhang A, Jing W, Ng JCK, Shinglot H, Seguin B, Salter AI, Riddell SR, Jensen MC, Gottschalk S, Moore PF, Torok-Storb B, Pollack SM. Zhang S, et al. Among authors: salter ai. Mol Cancer Ther. 2022 Jun 1;21(6):999-1009. doi: 10.1158/1535-7163.MCT-21-0726. Mol Cancer Ther. 2022. PMID: 35405743 Free PMC article.

2

Adoptive therapy with chimeric antigen receptor-modified T cells of defined subset composition.

Riddell SR, Sommermeyer D, Berger C, Liu LS, Balakrishnan A, Salter A, Hudecek M, Maloney DG, Turtle CJ. Riddell SR, et al. Cancer J. 2014 Mar-Apr;20(2):141-4. doi: 10.1097/PPO.0000000000000036. Cancer J. 2014. PMID: 24667960 Free PMC article. Review.

3

A BiTE from cancer's intracellular menu.

Salter AI, Riddell SR. Salter AI, et al. Nat Biotechnol. 2015 Oct;33(10):1040-1. doi: 10.1038/nbt.3370. Nat Biotechnol. 2015. PMID: 26448086 No abstract available.

4

Fully human CD19-specific chimeric antigen receptors for T-cell therapy.

Sommermeyer D, Hill T, Shamah SM, Salter AI, Chen Y, Mohler KM, Riddell SR. Sommermeyer D, et al. Among authors: salter ai. Leukemia. 2017 Oct;31(10):2191-2199. doi: 10.1038/leu.2017.57. Epub 2017 Feb 16. Leukemia. 2017. PMID: 28202953 Free PMC article.

5

Chimeric antigen receptor-modified T cells: CD19 and the road beyond.

Salter AI, Pont MJ, Riddell SR. Salter AI, et al. Blood. 2018 Jun 14;131(24):2621-2629. doi: 10.1182/blood-2018-01-785840. Epub 2018 May 4. Blood. 2018. PMID: 29728402 Free PMC article. Review.

6

Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function.

Salter AI, Ivey RG, Kennedy JJ, Voillet V, Rajan A, Alderman EJ, Voytovich UJ, Lin C, Sommermeyer D, Liu L, Whiteaker JR, Gottardo R, Paulovich AG, Riddell SR. Salter AI, et al. Sci Signal. 2018 Aug 21;11(544):eaat6753. doi: 10.1126/scisignal.aat6753. Sci Signal. 2018. PMID: 30131370 Free PMC article.

7

Logic-Gated ROR1 Chimeric Antigen Receptor Expression Rescues T Cell-Mediated Toxicity to Normal Tissues and Enables Selective Tumor Targeting.

Srivastava S, Salter AI, Liggitt D, Yechan-Gunja S, Sarvothama M, Cooper K, Smythe KS, Dudakov JA, Pierce RH, Rader C, Riddell SR. Srivastava S, et al. Among authors: salter ai. Cancer Cell. 2019 Mar 18;35(3):489-503.e8. doi: 10.1016/j.ccell.2019.02.003. Cancer Cell. 2019. PMID: 30889382 Free PMC article.

8

Tinkering in the garage - tuning CARs for safety.

Salter AI, Riddell SR. Salter AI, et al. Nat Rev Clin Oncol. 2019 Sep;16(9):530-532. doi: 10.1038/s41571-019-0240-2. Nat Rev Clin Oncol. 2019. PMID: 31209340 No abstract available.

9

Multispecific Targeting with Synthetic Ankyrin Repeat Motif Chimeric Antigen Receptors.

Balakrishnan A, Rajan A, Salter AI, Kosasih PL, Wu Q, Voutsinas J, Jensen MC, Plückthun A, Riddell SR. Balakrishnan A, et al. Among authors: salter ai. Clin Cancer Res. 2019 Dec 15;25(24):7506-7516. doi: 10.1158/1078-0432.CCR-19-1479. Epub 2019 Sep 23. Clin Cancer Res. 2019. PMID: 31548346 Free PMC article.

10

γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma.

Pont MJ, Hill T, Cole GO, Abbott JJ, Kelliher J, Salter AI, Hudecek M, Comstock ML, Rajan A, Patel BKR, Voutsinas JM, Wu Q, Liu L, Cowan AJ, Wood BL, Green DJ, Riddell SR. Pont MJ, et al. Among authors: salter ai. Blood. 2019 Nov 7;134(19):1585-1597. doi: 10.1182/blood.2019000050. Blood. 2019. PMID: 31558469 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page